Michael D. West, Ph.D., is the key driving force behind the concept of the LifeMap Discovery database. He is a pioneer in the field of stem cell research and has extensive academic and business experience in age-related degenerative diseases, telomerase molecular biology and human embryonic stem cell research and development. Dr. West is the CEO of BioTime, Inc. and has served on the BioTime Board of Directors since 2002. Prior to joining BioTime, Dr. West served as President and Chief Scientific Officer of Advanced Cell Technology, Inc., a company engaged in developing human stem cell technology for use in regenerative medicine. Dr. West also founded Geron Corporation where he initiated and managed programs in telomerase diagnostics, oligonucleotide-based telomerase inhibition as anti-tumor therapy, and the cloning and use of telomerase in telomerase-mediated therapy wherein telomerase is utilized to immortalize human cells, and he initiated and managed the original collaborative effort that led to the first isolation of human embryonic stem and embryonic germ cells. Dr. West is an inventor named on over 60 patents and patent applications in the field of biotech and also serves as an Adjunct Professor of Bioengineering at the University of California, Berkeley.
Dr. West received a B.S. Degree from Rensselaer Polytechnic Institute in 1976, an M.S. Degree in Biology from Andrews University in 1982, and a Ph.D. from Baylor College of Medicine in 1989 conentrating on the biology of cellular aging. Dr. West's complete CV and background on his research interests are available online at: www.michaelwest.org.
Mr. Guan-Golan is the CEO of LifeMap Sciences and was a founding member of the company, as well as member of the founding team of Xennex, Inc, which was acquired by LifeMap Sciences. He was CEO and senior executive at three startup companies in Hong Kong, Israel and Boston, after completing 5 years of service in the Israeli Defense Forces.
Yaron holds an MBA from the Hong Kong University of Science and Technology and a Bachelors of Sciences from the Open University of Israel.
Nafees Malik, M.D., is Chief Operating Officer at AgeX Therapeutics. He is an M.D. with a Master’s degree from the University of Cambridge. His 15 year career has involved roles spanning clinical medicine, investment banking, biopharmaceutical companies, research and academic institutions, and strategy consulting. For many years now, he has focused on the strategic and commercial analysis of cell and gene therapies and regenerative medicines. He is also Head of Cell and Gene Therapy at Juvenescence.